Ellen Goode, PhD, a Mayo Clinic investigator and author of the paper on the HNF1B gene study says, “Through the combined efforts of this consortium, and all the data sharing, we are much closer to understanding the inherited factors in these diseases.”
The results of the study may provide researchers with a new approach to predicting who will develop ovarian cancer which can lead to earlier treatment and better outcomes.
Dr. Goode said, “This has potential clinical implications for improving our understanding of how the disease begins, for better identification of ovarian cancer subtypes and for developing novel treatment approaches.”
Mayo Clinic. Novel Gene Drives Development of Different Types of Ovarian Cancer, Mayo Led Study Finds. Web. April 1, 2013.
National Cancer Institute. What Is Cancer? Web. April 1, 2013.
Medline Plus. Ovarian Disorders. April 1, 2013.
Centers for Disease Control and Prevention. Gynecologic Cancers: Ovarian Cancer. Web. April 1, 2013.
National Cancer Institute. Ovarian Cancer. Web. April 1, 2013.
Reviewed April 3, 2013
by Michele Blacksberg RN
Edited by Jody Smith